Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Financial Statements


Vaxcyte Financial Overview

Vaxcyte's market cap is currently ―. The company's EPS TTM is $-3.461; its P/E ratio is -14.66; Vaxcyte is scheduled to report earnings on November 7, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -70.86M$ -84.68M$ -57.92M$ -48.53M$ -39.06M
EBITDA$ -71.56M$ -82.78M$ -55.56M$ -46.36M$ -36.69M
Net Income Common Stockholders$ -60.46M$ -78.05M$ -57.92M$ -48.53M$ -38.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 822.04M$ 931.38M$ 362.23M$ 354.50M$ 334.64M
Total Assets$ 1.01B$ 1.01B$ 412.06M$ 411.62M$ 402.72M
Total Debt$ 16.59M$ 17.94M$ 19.78M$ 21.20M$ 22.41M
Net Debt$ -805.45M$ -913.43M$ -342.44M$ -333.30M$ -312.23M
Total Liabilities$ 63.39M$ 52.56M$ 52.75M$ 45.12M$ 43.17M
Stockholders Equity$ 944.77M$ 953.61M$ 359.31M$ 366.50M$ 359.54M
Cash Flow-
Free Cash Flow$ -53.30M$ -66.37M$ -39.39M$ -40.06M$ -30.62M
Operating Cash Flow$ -47.69M$ -65.22M$ -38.55M$ -39.13M$ -27.70M
Investing Cash Flow$ -448.10M$ -35.95M$ 34.71M$ 26.16M$ 49.67M
Financing Cash Flow$ 41.56M$ 656.63M$ 44.02M$ 49.88M$ 111.02M
Currency in USD

Vaxcyte Earnings and Revenue History

Vaxcyte Debt to Assets

Vaxcyte Cash Flow

Vaxcyte Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis